Meeting a deadline Congress set for a report assessing the US infant formula supply chain and identifying potential solutions to vulnerabilities didn’t stop criticism of the Food and Drug Administration not only from lawmakers, but also from its former food policy chief.
On the same day the agency published “a national strategy outlining actions” for ensuring consistent supply of formula, including specialty...





